Lithuanian Liebowitz Social Anxiety Scale Shows High Reliability in Young Adults

Quantifying Social Anxiety in Clinical Practice

Social anxiety disorder is a chronic condition causing significant impairment in occupational and social functioning, often requiring targeted pharmacological or psychological intervention [1, 2]. Selective serotonin reuptake inhibitors demonstrate efficacy in these patients, with meta-analytic data showing a mean reduction in the Liebowitz Social Anxiety Scale (LSAS) of 13.46 points (95% CI, 10.59 to 16.32) compared to placebo [3, 4]. Cognitive behavioral therapy also shows substantial effects, particularly in patients with high baseline severity where the effect size reaches a Cohen d of -1.13 (95% CI, -1.39 to -0.88), compared to -0.54 in those with mild symptoms [5]. The LSAS remains the clinical standard for quantifying fear and avoidance behaviors, but its utility in global practice depends on rigorous linguistic and cultural validation to ensure diagnostic accuracy across diverse populations [3, 6]. A recent study evaluates the psychometric properties of a Lithuanian translation to determine its reliability in modern clinical practice.

Validation in a Young Adult Cohort

Social anxiety disorder typically begins during the critical developmental windows of adolescence or young adulthood, periods where the condition can exert damaging effects on an individual's psychosocial development. Because early identification is essential for mitigating long term impairment, clinicians require validated assessment tools tailored to these specific age groups. To address this need in Eastern Europe, researchers tested the factor structure (the underlying dimensions and categories of symptoms the test measures) and internal consistency (a measure of how reliably different items on the test gauge the same clinical construct) of the Lithuanian translation of the Liebowitz Social Anxiety Scale Self-Report version. The study sample consisted of 452 young adult volunteers with a mean age of 21.3 years. Within this cohort, 69.7% of the study participants were female, reflecting a demographic frequently seen in clinical presentations of social anxiety. By focusing on this non-clinical young adult population, the researchers established how the translation performs in a group at the peak age of onset, ensuring that the self-report tool accurately captures the nuances of social interaction and performance anxieties before they progress into chronic clinical disability.

Structural Analysis and Internal Consistency

The Liebowitz Social Anxiety Scale and its self-report version have served as primary assessment tools for clinicians for nearly 40 years. Despite this long history of use, researchers continue to debate the factor structure of the instrument, which refers to the specific underlying dimensions of symptoms the scale actually measures. To clarify how the Lithuanian translation functions, the researchers tested two distinct structural models. The first was a single-factor model where all anxiety, fear, and avoidance ratings load onto one unified factor. The second was a higher-order factor model (a hierarchical structure that groups specific symptoms into subcategories which then feed into broader domains) designed to capture more granular clinical data. This complex model included two second-order scales, an anxiety and fear scale and an avoidance scale, which were further divided into four first-order subscales: social interaction anxiety, performance anxiety, social interaction avoidance, and performance avoidance. To evaluate the reliability of these models, the study utilized Cronbach’s alpha, a statistical measure reflecting how closely related a set of items are as a group. The Lithuanian version of the self-report scale demonstrated excellent internal consistency for the total score, scales, and subscales, with Cronbach’s alpha values ranging from 0.85 to 0.96. Confirmatory factor analysis, a statistical method used to verify if the collected data matches a hypothesized measurement model, showed that both the single-factor and higher-order models had an acceptable fit. This was evidenced by a Root Mean Square Error of Approximation (RMSEA) between 0.062 and 0.067 and a Comparative Fit Index (CFI) between 0.93 and 0.94. However, the researchers noted strong associations between the scales and subscales, with correlations exceeding 0.80. These high correlations suggest that while subscales can provide nuanced information during an individual clinical assessment, the total score remains the most robust and informative metric for general research and screening purposes.

Statistical Fit and Clinical Interpretation

To validate the structural integrity of the Lithuanian translation, the researchers employed confirmatory factor analysis to verify the factor structure of the observed variables. This analysis confirmed that both the single-factor model and the more complex higher-order model demonstrated an acceptable data fit. Specifically, the Root Mean Square Error of Approximation (RMSEA) for the models ranged from 0.062 to 0.067, where values below 0.08 typically indicate a reasonable error of approximation in the population. Furthermore, the Comparative Fit Index (CFI) for the models ranged from 0.93 to 0.94, meeting the standard threshold of 0.90 for an acceptable model fit relative to a null model. Despite the statistical validity of the subscales, the study identified strong correlations between the scales and subscales that exceeded 0.80. These high correlations suggest that the different dimensions of social anxiety measured by the tool, such as performance anxiety versus social interaction avoidance, overlap significantly in this population. From a research perspective, these strong associations suggest that individual subscale scores may be less informative than the total score in cross-sectional research, as the subscales may not be measuring sufficiently distinct phenomena. However, for the practicing physician, these subscale scores may still provide nuanced information during individual clinical assessment, allowing for a more detailed exploration of a patient's specific triggers and behavioral patterns even when the total score remains the primary indicator of severity.

Future Directions for Diagnostic Validation

While the current findings establish a strong foundation for the Lithuanian version of the Liebowitz Social Anxiety Scale Self-Report, the authors recommend further research in representative and clinical samples to verify these results. Because the initial validation was conducted on a volunteer group of 452 young adults with a mean age of 21.3 years, extending the research to a broader, more diverse population is necessary to ensure the tool remains accurate across different age groups and socioeconomic backgrounds. More importantly, testing the scale within a clinical sample of patients diagnosed with social anxiety disorder will determine if the high internal consistency, which reached Cronbach’s alpha values of 0.85 to 0.96, translates effectively from a non-clinical population to a psychiatric setting where symptom severity is typically higher. Future studies should also prioritize testing the convergent and discriminant validity of the instrument. Convergent validity (the degree to which the scale correlates with other measures of the same construct, such as other anxiety inventories) and discriminant validity (the degree to which the scale is distinct from unrelated constructs, such as general intelligence) are essential for clinical certainty. Establishing these parameters ensures the scale specifically measures social anxiety rather than generalized distress or other comorbid conditions. By confirming that the Lithuanian translation accurately distinguishes social anxiety from other psychological phenomena, researchers can provide practitioners with a more precise diagnostic tool for guiding treatment decisions and monitoring patient progress over time.

References

1. Hedges DW, Brown BL, Shwalb DA, Godfrey K, Larcher AM. The efficacy of selective serotonin reuptake inhibitors in adult social anxiety disorder: a meta-analysis of double-blind, placebo-controlled trials.. Journal of psychopharmacology (Oxford, England). 2007. doi:10.1177/0269881106065102

2. Mayo‐Wilson E, Dias S, Mavranezouli I, et al. Psychological and pharmacological interventions for social anxiety disorder in adults: a systematic review and network meta-analysis. The Lancet Psychiatry. 2014. doi:10.1016/s2215-0366(14)70329-3

3. Li X, Hou Y, Su Y, Liu H, Zhang B, Fang S. Efficacy and tolerability of paroxetine in adults with social anxiety disorder: A meta-analysis of randomized controlled trials.. Medicine. 2020. doi:10.1097/MD.0000000000019573

4. Mitsui N, Fujii Y, Asakura S, et al. Antidepressants for social anxiety disorder: A systematic review and meta-analysis.. Neuropsychopharmacology reports. 2022. doi:10.1002/npr2.12275

5. Scholten W, Seldenrijk A, Hoogendoorn A, et al. Baseline Severity as a Moderator of the Waiting List-Controlled Association of Cognitive Behavioral Therapy With Symptom Change in Social Anxiety Disorder: A Systematic Review and Individual Patient Data Meta-analysis.. JAMA psychiatry. 2023. doi:10.1001/jamapsychiatry.2023.1291

6. Menezes GBD, Coutinho ESF, Fontenelle LF, Vigne P, Figueira I, Versiani M. Second-generation antidepressants in social anxiety disorder: meta-analysis of controlled clinical trials.. Psychopharmacology. 2011. doi:10.1007/s00213-010-2113-3